The impact of the interleukin 12/23 inhibitor ustekinumab on the risk of infections in patients with psoriatic arthritis

A Zabotti, D Goletti, E Lubrano… - Expert Opinion on Drug …, 2020 - Taylor & Francis
ABSTRACT Introduction: Psoriatic arthritis (PsA) is characterized by chronic inflammation
mediated by pro-inflammatory cytokines, with clinical features resulting from dysfunctional …
被引用次数：14 相关文章

The impact of the interleukin 12/23 inhibitor ustekinumab on the risk of infections in patients with psoriatic arthritis

A Zabotti, D Goletti, E Lubrano… - Expert opinion on drug …, 2020 - pubmed.ncbi.nlm.nih.gov
Introduction: Psoriatic arthritis (PsA) is characterized by chronic inflammation mediated by
pro-inflammatory cytokines, with clinical features resulting from dysfunctional integrated …

[引用][C] The impact of the interleukin 12/23 inhibitor ustekinumab on the risk of infections in patients with psoriatic arthritis

A Zabotti, D Goletti, E Lubrano, F Cantini - 2020 - ricerca.unityfvg.it

The impact of the interleukin 12/23 inhibitor ustekinumab on the risk of infections in patients with psoriatic arthritis.

A Zabotti, D Goletti, E Lubrano… - Expert Opinion on Drug …, 2019 - europepmc.org
Introduction: Psoriatic arthritis (PsA) is characterized by chronic inflammation mediated by
pro-inflammatory cytokines, with clinical features resulting from dysfunctional integrated …

[引用][C] The impact of the interleukin 12/23 inhibitor ustekinumab on the risk of infections in patients with psoriatic arthritis

A Zabotti, D Goletti, E Lubrano, F Cantini - EXPERT OPINION ON …, 2020 - air.uniud.it
The impact of the interleukin 12/23 inhibitor ustekinumab on the risk of infections in patients with
psoriatic arthritis IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT …